🔎 Trials Near Me

Akèy › Myelom Miltip › Texas › Austin

Etid klinik pou Myelom Miltip nan Austin, TX

8 etid pou Myelom Miltip ap chèche patisipan nan sit nan ak bò kote Austin (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

Ap rekriteFaz 3
  • St. David's South Austin Medical Center, Austin
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07258511

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

Ap rekriteFaz 1/2
  • Research Site, Austin
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05850234

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

Ap rekriteFaz 1
  • Texas Oncology - Central/South Texas /ID# 268563, Austin
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT05650632

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

Ap rekriteFaz 4
  • St. David's South Austin Medical Center, Austin
Laj 18 ak plis · Tout sèks · Mizajou Jul 1, 2026 · NCT06057402

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

Ap rekriteFaz 2
  • Texas Oncology, Austin
Laj 18 ak plis · Tout sèks · Mizajou Apr 22, 2026 · NCT05972135

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Elligo Health Research, Inc., Austin
Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881

Etid Myelom Miltip nan lòt vil

Lòt etid nan Austin

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.